Mobile version

Table on assessment times for Concerned Member State cases 2019

09 August 2019, Updated 03 March 2021

Table 1. Concerned member state cases

Concerned member state cases Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs
No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2018  26  30  -4  109  106  97 
2nd quarter 2018 21 30  -9  115 115 100 
3rd quarter 2018 16 30 -14 97 94 97
4th quarter 2018 18 30 -12 78 75 96
1st quarter 2019 20 30 -10 101 99 98
2nd quarter 2019 23 30 -7 113 109 96
3rd quarter 2019
18 30 -12 127 121 95
4th quarter 2019
 42 30 12 39 35 90

Tabel 2. Concerned member state cases - Human medicines

Concerenced member state cases - HUM Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs
No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2018  27  30  -3  88  85  97 
2nd quarter 2018  21  30  -9  104 104 100 
3rd quarter 2018
14 30 -16 88 88 100
4th quarter 2018 18 30 -12 70 67 96
1st quarter 2019
20 30 -10 88 86 98
2nd quarter 2019
24 30 -6 98 94 96
3rd quarter 2019
17 30 -13 104 99 95
4th quarter 2019
46 30 16 33 29 88

Tabel 3. Concerned member state cases - Veterinary medicines

Concerenced member state cases - VET Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs
No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2018  21  30  -9  21  21  100 
2nd quarter 2018  23  30 -7 11 11 100
3rd quarter 2018 36 30 6 9 6 67
4th quarter 2018 16 30 -14 8 8 100
1st quarter 2019
20 30 -10 13 13 100
2nd quarter 2019
19 30 -11 15 15 100
3rd quarter 2019
22 30 -8 23 22 96
4th quarter 2019
21 30 -9 6 6 100